Clovoxamine

Other namesDU-23811

Routes of
administrationOral

ATC code

• none

Legal status

• In general: uncontrolled

Clovoxamine

Clinical data
Other names	DU-23811
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name (E)-1-(4-chlorophenyl)-5-methoxy-1-pentanone O-(2-aminoethyl)oxime
CAS Number	54739-19-4 Y fumarate: 54739-21-8 Y
PubChem CID	6335903
ChemSpider	4891461 N
UNII	7I22J7RY2A fumarate: 21VG81S0IX Y
ChEMBL	ChEMBL2105603 N
CompTox Dashboard (EPA)	DTXSID501023903
Chemical and physical data
Formula	C14H21ClN2O2
Molar mass	284.78 g·mol−1
3D model (JSmol)	Interactive image
SMILES COCCCCC(=NOCCN)C1=CC=C(C=C1)Cl
InChI InChI=1S/C14H21ClN2O2/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12/h5-8H,2-4,9-11,16H2,1H3/b17-14+ N Key:XXPVSQRPGBUFKM-SAPNQHFASA-N N
NY (what is this?)  (verify)

Clovoxamine (INN; development code DU-23811) is a drug that was discovered in the 1970s and was subsequently investigated as an antidepressant and anxiolytic agent but was never marketed.^[1][2][3] It acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), with little affinity for the muscarinic acetylcholine, histamine, adrenergic, and serotonin receptors.^[4][5] The compound is structurally related to fluvoxamine.